Woodline Partners’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $958K | Hold |
100,108
| – | – | 0.01% | 808 |
|
|
2025
Q1 | $931K | Buy |
+100,108
| New | +$931K | 0.01% | 770 |
|
|
2024
Q4 | – | Sell |
-55,866
| Closed | -$1.31M | – | 1002 |
|
|
2024
Q3 | $1.31M | Sell |
55,866
-32,790
| -37% | -$771K | 0.01% | 494 |
|
|
2024
Q2 | $1.42M | Buy |
+88,656
| New | +$1.42M | 0.01% | 439 |
|
|
2023
Q4 | – | Sell |
-410,435
| Closed | -$5.65M | – | 657 |
|
|
2023
Q3 | $5.65M | Hold |
410,435
| – | – | 0.07% | 302 |
|
|
2023
Q2 | $6.99M | Hold |
410,435
| – | – | 0.08% | 254 |
|
|
2023
Q1 | $6.6M | Buy |
410,435
+111,419
| +37% | +$1.79M | 0.09% | 251 |
|
|
2022
Q4 | $2.27M | Buy |
299,016
+57,917
| +24% | +$440K | 0.03% | 459 |
|
|
2022
Q3 | $2.12M | Sell |
241,099
-48,073
| -17% | -$423K | 0.03% | 447 |
|
|
2022
Q2 | $2.07M | Buy |
289,172
+23,011
| +9% | +$165K | 0.03% | 415 |
|
|
2022
Q1 | $2.85M | Buy |
266,161
+1,416
| +0.5% | +$15.2K | 0.05% | 331 |
|
|
2021
Q4 | $3.73M | Sell |
264,745
-101,290
| -28% | -$1.43M | 0.05% | 325 |
|
|
2021
Q3 | $6.44M | Buy |
+366,035
| New | +$6.44M | 0.11% | 222 |
|